FOLIC ACID INJECTION, USP 5 MG — DIN 02139480
FOLIC ACID (SODIUM FOLATE) : 5 MG · FRESENIUS KABI CANADA LTD · SOLUTION · wholesale supply in Canada
Health Canada status: MARKETED
What is FOLIC ACID INJECTION, USP?
FOLIC ACID INJECTION, USP 5 MG contains FOLIC ACID (SODIUM FOLATE) : 5 MG. It is listed in the Health Canada Drug Product Database under DIN 02139480, held by FRESENIUS KABI CANADA LTD, supplied as SOLUTION for INTRAMUSCULAR ; SUBCUTANEOUS ; INTRAVENOUS administration. Health Canada currently lists it as marketed, status dated 14-Jan-2022. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
What is FOLIC ACID INJECTION, USP used for?
Treatment of megaloblastic anemias due to folate deficiency (tropical/nontropical sprue, nutritional origin, pregnancy, infancy, or childhood). Use only when folate deficiency is confirmed.
Authorized indication as written in the Health Canada product monograph. For healthcare professionals and licensed purchasers; this is not medical advice.
How much does Folic Acid cost around the world?
Folic Acid is listed on 9 of the national price registers Nexara ingests. Each country publishes on a different basis, so those figures are not comparable with one another — or with a Canadian wholesale price.
What a market publishes matters more than the number it publishes. Australia publishes a ex-manufacturer; Bahrain publishes a retail (max); Greece publishes a producer price (ex-factory). Comparing an ex-factory ceiling against a pharmacy public price tells you nothing about either, and comparing either against a Canadian landed cost tells you less.
| Market | Price basis published there | Brands | Packs listed | Range |
|---|---|---|---|---|
| United States | acquisition | 1 | 24 | USD███.██ |
| Saudi Arabia | public | 14 | 20 | SAR███.██ |
| Bahrain | retail (max) | 5 | 11 | BHD███.██ |
| United Arab Emirates | public | 5 | 10 | AED███.██ |
| Greece | producer price (ex-factory) | 7 | 7 | EUR███.██ |
| Australia | ex-manufacturer | 3 | 6 | AUD███.██ |
| South Africa | single exit price | 2 | 6 | ZAR███.██ |
| United Kingdom | hospital | 2 | 2 | GBP███.██ |
| Iceland | max wholesale | 1 | 1 | ISK███.██ |
87 pack listings across 40 brand entries and 8 price bases, refreshed 08 Sep 2026. Ranges span every Folic Acid pack in that market, so a high figure is usually a larger pack rather than the same product.
Canada publishes no comparable public list price. For a delivered Canadian price on a licensed account, verify your licence — it takes about a minute.
Is there a generic Folic Acid in Canada, and who makes it?
Every market authorization holder with a Canadian DIN for this molecule, and how many of their listings Health Canada currently shows as marketed.
30 holders have a Canadian DIN containing Folic Acid, across 37 DINs, of which 3 are currently marketed. Marketed count is the number that matters: an approval that is not marketed cannot be bought.
| Market authorization holder | DINs | Marketed | Brand names | Position |
|---|---|---|---|---|
| AA PHARMA INC UNIT 1 1165 Creditstone Road Vaughan Ontario Canada L4K 4N7 | 1 | 1 | FOLIC ACID | Sourceable in Canada |
| FRESENIUS KABI CANADA LTD | 1 | 1 | FOLIC ACID INJECTION, USP | Sourceable in Canada |
| JAMP PHARMA CORPORATION | 1 | 1 | JAMP-FOLIC ACID | Sourceable in Canada |
| GREAT EARTH COMPANIES, INC. | 2 | 0 | FOLIC ACID 0.4MG, FOLIC ACID 0.8MG | No marketed DIN |
| KRIPPS PHARMACY LTD. | 2 | 0 | FOLIC ACID TAB 25MG, FOLIC ACID TAB 5MG | No marketed DIN |
| LEDERLE CYANAMID CANADA INC. | 2 | 0 | FOLVITE INJ 5MG/ML, FOLVITE TAB 5MG | No marketed DIN |
| NATROL, INC. | 2 | 0 | FOLIC ACID 400MCG TAB, FOLIC ACID 800MCG TAB | No marketed DIN |
| SANDOZ CANADA INCORPORATED | 2 | 0 | FOLIC ACID INJECTION USP, SANDOZ FOLIC ACID | No marketed DIN |
| STANLEY PHARMACEUTICALS, A DIVISION OF VITA HEALTH PRODUCTS INC. | 2 | 0 | FOLIC ACID (1MG TABLET), FOLIC ACID TAB 5MG | No marketed DIN |
| SWISS HERBAL REMEDIES LTD. | 2 | 0 | FOLIC ACID 0.4 MG TABLET, FOLIC ACID TAB 1MG | No marketed DIN |
| D.C. LABS LIMITED | 1 | 0 | FOLIC ACID TABLETS 5MG | No marketed DIN |
| GARDEN STATE NUTRITIONALS | 1 | 0 | FOLIC ACID 0.4MG DIETARY SUPPLEMENT | No marketed DIN |
Health Canada’s Drug Product Database does not flag which listing is the originator and which are subsequent-entry products, so Nexara does not label them here. Interchangeability is determined provincially, not federally — confirm for your province before a formulary switch. Nexara can confirm which of these is actually obtainable, and on what lead time, per order.
How is it supplied and stored?
Pack configuration, storage class and the handling constraints that drive cold-chain planning. One DIN can cover more than one pack size, and the pack — not the DIN — is what gets priced, shipped and invoiced.
| Strength on the label | 5 MG |
|---|---|
| Dosage form | SOLUTION |
| Route | INTRAMUSCULAR ; SUBCUTANEOUS ; INTRAVENOUS |
| Pack configuration (monograph) | 10 mL multiuse vial with aluminum flip-top seal. Packaged individually. |
| Storage | Store at room temperature (15°C to 30°C). Protect from light. Discard punctured vial within 28 days. |
Before an order line is unambiguous Nexara needs the strength, the pack size and the presentation.
Substance and classification
| Active substance | Folic Acid |
|---|---|
| ATC code | B03BB01 |
| AHFS class | 28:12.92 ; 40:12.00 |
| Biosimilar biologic | No |
Health Canada record and identifiers
The regulatory facts straight from the Drug Product Database, plus every identifier form Nexara accepts on a purchase order. A DIN written without its leading zeros is the commonest reason an order line fails to match.
| DIN (8-digit, as used in ordering) | 02139480 |
|---|---|
| DIN (unpadded, as printed on some documents) | 2139480 |
| Brand name | FOLIC ACID INJECTION, USP |
| Generic / active ingredient | FOLIC ACID (SODIUM FOLATE) : 5 MG |
| Market authorization holder | FRESENIUS KABI CANADA LTD |
| Health Canada schedule | Ethical |
| ATC code | B03BB01 |
| ATC anatomical main group | B — Blood and blood-forming organs |
| ATC therapeutic subgroup | B03BB |
| Current status | MARKETED |
| Status date | 14-Jan-2022 |
| Original market date | 1992-12-31 00:00:00 |
| Status source | Live Health Canada DPD sync |
Verify on the primary sources
How is it administered?
Adults/children: up to 1 mg daily. Maintenance: 0.1-0.8 mg daily depending on age/condition. Administered IM, SC, or IV (must be diluted for IV use).
Included because it drives pack selection and wastage. Consult the monograph.
Contraindications
Hypersensitivity; untreated cobalamin deficiency; neonates (contains benzyl alcohol); patients with impaired renal function or premature neonates with immature kidneys.
Warnings and precautions
Rule out B12 deficiency before use; folic acid can mask pernicious anemia. Contains benzyl alcohol (risk of gasping syndrome in neonates) and aluminum (risk of toxicity in renal impairment).
What can be used instead?
Alternatives on every axis a buyer actually considers — the same molecule in another presentation, the same class, an adjacent class, or a fixed-dose combination. Every row is led by the marketed DIN count, because that is what can be bought this week.
1 · Same molecule, other Canadian presentations
3 of 37 Canadian DINs for this molecule are currently marketed. Marketed products are listed first.
| Product | Strength | Form | Holder | Health Canada status | DIN |
|---|---|---|---|---|---|
| FOLIC ACID | Strength | Tablet | AA PHARMA INC UNIT 1 1165 Creditstone Road Vaughan Ontario Canada L4K 4N7 | MARKETED | 00426849 |
| JAMP-FOLIC ACID | 5 MG | TABLET | JAMP PHARMA CORPORATION | MARKETED | 02366061 |
| ACIDE FOLIQUE 5 TAB | 5 MG | TABLET | PRO DOC LIMITEE | CANCELLED POST MARKET | 00563781 |
| FOLIC ACID | Strength | Capsule | SISU INC. 104A 3430 Brighton Avenue Burnaby British Columbia Canada V5A 3H4 | CANCELLED POST MARKET | 02240313 |
| FOLIC ACID (1MG TABLET) | 1 MG | TABLET | STANLEY PHARMACEUTICALS, A DIVISION OF VITA HEALTH PRODUCTS INC. | CANCELLED POST MARKET | 02231643 |
| FOLIC ACID 0.4 MG TABLET | 0.4 MG | TABLET | SWISS HERBAL REMEDIES LTD. | CANCELLED POST MARKET | 02241363 |
| FOLIC ACID 0.4MG | 0.4 MG | TABLET | GREAT EARTH COMPANIES, INC. | CANCELLED POST MARKET | 02230603 |
| FOLIC ACID 0.4MG DIETARY SUPPLEMENT | 0.4 MG | TABLET | GARDEN STATE NUTRITIONALS | CANCELLED POST MARKET | 02238506 |
| FOLIC ACID 0.8MG | 0.8 MG | TABLET | GREAT EARTH COMPANIES, INC. | CANCELLED POST MARKET | 02230602 |
| FOLIC ACID 1 MG | Strength | Tablet | PREFERRED NUTRITION INC. 153 Perth Street Acton Ontario Canada L7J 1C9 | CANCELLED POST MARKET | 02248692 |
2 · Same class — other molecules in ATC B03BB
| Molecule | Canadian brands | DINs | Marketed | Sourceable |
|---|---|---|---|---|
| Folic Acid | ACIDE FOLIQUE 5 TAB · FOLIC ACID · FOLIC ACID (1MG TABLET) · FOLIC ACID 0.4 MG TABLET · +27 more | 37 | 3 | Yes |
| Folic Acid, Combinations | B6, B12 & FOLIC ACID MULTI-VITAMIN TABLETS · FOLIC ACID & VITAMIN C · FOLIC ACID 1MG WITH C 20MG · FOLIC ACID 1MG WITH VITAMIN C · +2 more | 6 | 0 | Not in Canada |
A molecule with zero marketed DINs cannot be sourced domestically, however many approvals it holds — if one of these sits on a formulary or in an older protocol, that is the line to check.
3 · Adjacent classes in ATC B03B
| ATC subgroup | Molecules | DINs | Marketed |
|---|---|---|---|
| B03BA | Cobamamide · Cobamamide, Combinations · Cyanocobalamin · Cyanocobalamin, Combinations · Hydroxocobalamin · +2 more | 85 | 4 |
Not clinical advice. These tables describe what can be supplied in Canada, not what should be prescribed. Substitution within or across classes is a prescriber and pharmacist decision, and interchangeability is determined provincially.
What else is FOLIC ACID INJECTION, USP called?
The same molecule, Folic Acid, is registered under other names elsewhere. Buyers and prescribers searching from outside Canada — or working from a foreign prescription or tender document — often know it by one of these:
| Name | Script | Registered in |
|---|---|---|
| Folic Acid | Latin | Bahrain, Saudi Arabia |
| FOLITAB | Latin | Bahrain |
| FOLICUM | Latin | Bahrain, Saudi Arabia |
| AKFOLIC | Latin | Bahrain |
| FEROSE ® - F | Latin | United Arab Emirates |
| FOLIVITA TAB | Latin | Saudi Arabia |
| JORIVER FOLIC ACID | Latin | Bahrain |
| Metafolin | Latin | Iceland |
| TRI-B | Latin | Saudi Arabia |
Names are taken from national medicine registers and published price lists. A product registered abroad is not authorized for sale in Canada unless it holds its own DIN; import is possible only through the routes Health Canada permits.
What is Folic Acid called in other languages?
Buyers, prescribers and procurement teams outside Canada often search for the ingredient in their own script. These are phonetic renderings of the ingredient name Folic Acid, published to help those searches reach this page.
| Language | Folic Acid |
|---|---|
| Arabic العربية | حمض الفوليك |
| Chinese (Simplified) 简体中文 | 叶酸 |
| Russian Русский | фолиевая кислота |
| Spanish Español | ácido fólico |
| French Français | acide folique |
| Portuguese Português | ácido fólico |
| German Deutsch | Folsäure |
| Japanese 日本語 | 葉酸 |
These are transliterations of the ingredient name, generated automatically and published only where two independent checks agreed. They are not registered local trade names and carry no marketing authorisation in any market. Always confirm a product against its local registration before ordering.
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address. Patients and unlicensed buyers are routed to a partner pharmacy.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Why is there no price on this page?
Nexara quotes a delivered Canadian price per order, against a verified licence. Foreign list prices are published on incompatible bases and are not a guide to what any buyer can obtain here, so this page shows which markets list the molecule and on what basis, and nothing more.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.